Teva’s MS drug and generics to add black box warning for anaphylaxis

The FDA has issued a new boxed warning for Teva Pharmaceuticals' multiple sclerosis drug Copaxone and generic versions marketed by other companies after some patients had serious allergic reactions. Most patients who had anaphylaxis after ...